Abstract
We introduce LytU, a short member of the lysostaphin family of zinc-dependent pentaglycine endopeptidases. It is a potential antimicrobial agent for S. aureus infections and its gene transcription is highly upregulated upon antibiotic treatments along with other genes involved in cell wall synthesis. We found this enzyme to be responsible for the opening of the cell wall peptidoglycan layer during cell divisions in S. aureus. LytU is anchored in the plasma membrane with the active part residing in the periplasmic space. It has a unique Ile/Lys insertion at position 151 that resides in the catalytic site-neighbouring loop and is vital for the enzymatic activity but not affecting the overall structure common to the lysostaphin family. Purified LytU lyses S. aureus cells and cleaves pentaglycine, a reaction conveniently monitored by NMR spectroscopy. Substituting the cofactor zinc ion with a copper or cobalt ion remarkably increases the rate of pentaglycine cleavage. NMR and isothermal titration calorimetry further reveal that, uniquely for its family, LytU is able to bind a second zinc ion which is coordinated by catalytic histidines and is therefore inhibitory. The pH-dependence and high affinity of binding carry further physiological implications.
Introduction
The emergence and spread of new drug-resistant Staphylococcus aureus strains are a growing global concern, particularly in hospital settings1. The primary and key defence mechanism of the pathogen is to increase the number of peptidoglycan (PG) layers in its cell wall (CW)2. Selective pressure driving this change results from the extensive use of the most prominent antistaphylococcal agents, beta-lactam antibiotics (e.g. methicillin) and glycopeptides (e.g. vancomycin) causing these antibiotics to become increasingly inefficient in combat against the new treatment-resistant strains3. The mechanism of action for these drugs is to interfere with the synthesis of S. aureus CW, i.e. its PG. Accordingly, targeting PG for lysis can serve antimicrobial function alone or in combination with other therapeutic approaches.
The target of this study, the sa0205 coding frame of the S. aureus genome, was identified as one of the highly induced genes in cultures treated with the aforementioned antibiotics4. It was shown to be under the control of the VraSR two-component system that regulates genes involved in CW peptidoglycan synthesis in S. aureus 5. Interestingly, transcription of sa0205 is upregulated 50- and 25-fold by cationic antimicrobial peptides and vancomycin, respectively. However, based on the amino acid sequence, the product of this coding frame was not a PG synthesizing enzyme but a putative lysostaphin family endopeptidase that hydrolyses PG.
Lysostaphin family endopeptidases are zinc-dependent enzymes that cleave pentaglycine interpeptide bridges of CW PG. They are utilized as autolysins or weapons against competing strains. Indeed, promising results on the use of lysostaphin as an antimicrobial agent have been reported6–10. Lysostaphin itself is secreted by Staphylococcus simulans biovar staphylolyticus and targets the CW of other staphylococci with its SH3b domain. Conjugation of this domain with a catalytic domain of S. aureus autolysin LytM produced chimeras that may supersede the efficacy of lysostaphin in their medical applications11, 12.
The catalytic mechanism of the lysostaphin family enzymes has recently been investigated13. It involves a zinc ion which polarizes the scissile peptide bond by coordinating the carbonyl oxygen, and two catalytic histidines which activate a water molecule or a hydroxide ion to act as a nucleophile to attack the carbonyl carbon. Involvement of a previously unacknowledged tyrosine residue as a hydrogen bond donor to the transition state was revealed. Although lysostaphin family members are widely regarded as zinc-dependent enzymes, a partial activity of LytM can be restored by Co2+, Mn2+ and Cu2+ ions14. The in vitro active pH range for both LytM and lysostaphin is 5–914–16 and the optimum for lysostaphin is 7.516.
Among the factors hampering investigations of lysostaphin family enzymes is the insolubility of their substrate, PG. Several alternative substrates and approaches have been proposed for activity assessment14, 17–19. None of these substrates has become commonly utilized and the primary analysis of activity remains the lysis of whole cells, which provides multiple variables and obstacles to study structure and catalysis. Furthermore, in situ studies are complicated due to the presence of other autolytic enzymes that are potentially able to compensate for their counterparts and thus a comprehensive registry of autolysins is necessary. Finally, the regulation of autolytic activity remains unclear and so far its cornerstone has been activation by cleavage of protoenzymes17, 20, 21.
Our study brings new insight into the lysostaphin family by introducing the product of the gene sa0205. Consistently with the present nomenclature, we call it LytU. Here we present solution structures of its catalytic domain and demonstrate the tight binding of a second zinc ion, which effectively inhibits the enzyme. The physiologically relevant affinity and pH sensitivity of this binding are pertinent to a regulation of catalytic activity. We examine catalysis of substrate and metal ion effect by monitoring pentaglycine cleavage by NMR.
Results
LytU is a member of the lysostaphin family
To retrieve information regarding the structural organization of LytU, we carried out an analysis of LytU primary structure and compared it to lysostaphin family members. Residues 7–25 of LytU are predicted to form a transmembrane helix followed by a short, disordered region (26–48) and a catalytic domain homologous to lysostaphin (i.e. LytM domain, Fig. 1a). Within this region, residues 74–167 contain the M23 family peptidase domain (Fig. 1a). Residues H76, D80, and H159 in LytU are expected to coordinate a zinc ion (Fig. 1b) and H125 and H157 to cleave peptide bonds between consecutive glycines22, 23. LytU lacks the CW targeting SH3b domain present in lysostaphin. A unique sequence feature of LytU is the insertion at residue position 151 in the otherwise conserved region. Among the different S. aureus subsp. aureus strains this residue is either isoleucine or lysine.
LytU affects cell division
To find a functional role for LytU in S. aureus lifecycle, we started by removing the gene from the genome. Deletion of LytU gene did not affect the bacterial growth of liquid or plate cultures indicating that LytU is not essential for S. aureus survival. However, when we examined S. aureus cells using scanning electron microscopy (EM) a small difference in the CW was found (Fig. 2). On the surface of ΔLytU cells, traces of the previous cell division plane could still be seen even though the next division was already on-going. The observed structure resembles the tearing edge of a paper sheet and the finding suggested that LytU is directly involved in the opening of the CW upon cell division.
Contrary to deletion of the LytU gene, its overexpression had a clear effect on the growth of S. aureus cells. The growth was arrested upon induction and a subsequent increase of cell lysis in the culture was observed (Fig. 3a,b). We further examined the cultures using EM, which revealed that while cell division for individual cells progressed uninterrupted and completed normally, daughter cell separation was blocked (Fig. 3c). Eventually, after a few divisions, the CW ruptured under the expansion pressure (Fig. 3d) thereby causing the increase of broken cells in the culture. This was observed as an increased stickiness of the EM samples and a noticeable presence of cell debris. The results suggest that excess of LytU impaired the mechanisms involved in the opening of the CW upon cell division.
LytU is anchored in the plasma membrane and its soluble part is extracytoplasmic
Fractionation experiment with the overexpressing strain showed that LytU is dominantly saturated in the cellular fraction containing the membrane. The orientation of the protein in the plasma membrane was then demonstrated by immunodetection of the C-terminal Strep-tag (Fig. 4). LytU-Strep was detected in whole cells and protoplasts. In addition, a significant amount of LytU-Strep was also present in the protoplast supernatant that contains the CW (Fig. 4a). Trypsin treatment degraded a major proportion of LytU-Strep in the protoplasts, indicating that the hydrophilic domain of LytU is on the outer surface of the membrane. The PrsA (protein secretion A) control, which is a known lipoprotein with a large extracytoplasmic domain24, behaved in a similar manner (Fig. 4b). Only traces of TrxA (thioredoxin A), which is a known cytoplasmic protein25, were detected in the protoplast supernatant, indicating that protoplast lysis was minimal and TrxA was not degraded in the trypsin treatment (Fig. 4c). The assay controls are shown in Supplementary Fig. S1.
To examine LytU distribution in the plasma membrane, we employed fluorescent confocal microscopy to observe the localization pattern of the GFPuv4-LytU fusion protein in exponentially growing S. aureus RN4220 (Fig. 4d). We observed the fluorescent protein only in the membrane, which is in good agreement with the results of our cell fractionation experiment. Overexpressed GFPuv4-LytU was distributed all over the cell membrane but higher fluorescence in septa could be seen as can be expected due to the presence of a double membrane and an enhancement effect of accumulated fluorescence. Interestingly, the slightly increased intensity at the sites where a new cell division plane is forming may suggest that at least part of the overexpressed GFPuv4-LytU could accumulate into the site of the next cell division.
LytU lyses S. aureus cells
We subjected whole cells from actively growing and late stationary S. aureus cultures to autolysis. These data indicated that, under the examined conditions, old cells do not significantly undergo autolysis while young cells do so (Supplementary Fig. S2). Next, in order to study the effect of LytU on S. aureus cells, we added purified recombinant LytU to S. aureus cell cultures. Intriguingly, we observed that LytU effectively lysed both cell types and that the effect was additive to the activity originating from the cells. EDTA chelation prevented autolysis in all cases indicating that the process is cation dependent. The effect of cations on cell lysis was similar in both old and young cells suggesting that cell components participating in LytU-stimulated lysis were similar as well.
LytU cleaves pentaglycine
We established the catalytic activity of LytU directly by monitoring pentaglycine cleavage by 1H NMR spectroscopy. This approach is direct, easily quantifiable, reproducible and real-time. A typical course of the reaction is shown in Fig. 5a. Identification of substrate and product peaks with 1H, 13C HMBC spectra revealed that LytU hydrolyses pentaglycine into di- and triglycine (Supplementary Fig. S3).
There was no significant difference in substrate cleavage between the full-length soluble LytU (residues 26–192) and LytU(49–192) that includes the catalytic domain (n = 2, t-test, alpha level 5%, two-tailed P = 0.26). This indicates that the N-domain does not need to be cleaved off for enzyme activation (Fig. 5b). Unexpectedly, the truncated LytU(70–192), containing the conserved M23 family domain was inactive but still structured, as inferred from its 1H, 15N HSQC spectrum (Supplementary Fig. S4). This underscores the importance of N-terminal residues in the catalytic domain for proper construction of the active site. In the LytU(49–192) structure (see below) residues I60-T63 form a strand-like conformation at the catalytic site end of the substrate-binding groove and they are thereby likely to assist in correct positioning of the catalytic residues. Moreover, Y67, located in the loop between the I60-T63 strand-like structure and β1 (residues 79–81), might have a role in catalysis as the corresponding Y204 in LytM was shown to be crucial for lytic activity13.
Both LytU forms, 151 Ile and Lys, are active, the lysine form being about 40% more efficient under the conditions studied. The activity significantly decreases at temperatures lower than 37 °C and increases when pH is raised from six to eight (Supplementary Fig. S5). The activity, particularly that of the Ile form, closely resembles that of active LytM(185–316) as could be expected considering the homology of the active sites. Most surprisingly, however, the deletion of the supposedly redundant LytU residue 151 rendered the enzyme completely inactive. The inactivation is not caused by a collapse of the protein structure, as the 1H, 15N HSQC spectrum indicates a folded protein (Supplementary Fig. S4). Of practical significance was a sharply increased activity when cofactors were other metal ions, namely Cu2+ and Co2+ (Fig. 5c). Pilot experiments exhibited further analogies with LytM13, Mn2+ reactivating the enzyme and Mg2+ and Ca2+ not having this effect, yet properties and diversity of potentially alternative cofactors remain a topic for future investigations. The differences in metal ion effects between pentaglycine cleavage activity measurements and cell lysis experiments (Supplementary Fig. S2) can be explained by the very different experimental setups. In NMR we observed the catalytic reaction between two pure components while in the autolysis assay the substrate is a whole cell. The CW is an exquisitely complex milieu with ion buffering capability and the measured outcome is the combined effect of a treatment on the substrate cell, i.e. CW components and all the autolytic activities present in the cells.
LytU catalytic domain binds a second zinc that inhibits the enzyme
We observed a substantial reduction in the pentaglycine cleavage in response to the increasing concentration of zinc ions (Fig. 5b) and sought to understand underlying reasons for reduced activity. To this end, we measured 1H, 15N HSQC spectra under varying ion concentrations (Supplementary Figs S4 and S6). Indeed, 1H, 15N HSQC and histidine-optimized 1H, 15N HMBC spectra unequivocally showed that in the presence of a 2.5-fold excess of zinc ions the enzyme retains its fold and the catalytic H125 and H157 coordinate a second zinc ion. Although 1H, 15N HSQC spectra displayed a continuation of zinc ion binding also to LytM(185–316) (Supplementary Fig. S4), even a 5-fold molar excess of ion reduced catalytic activity by a mere 16%. Since no structure of a LytM domain with a second bound Zn2+ has been reported and inhibition has not previously been demonstrated, we conclude that this property is unique to LytU. Notably, a partial cleavage activity was observed for the apo LytU is likely due to tight metal binding of the protein and regaining of a limited activity by acquiring ions accessible as unavoidable trace impurities in the preceding concentration and reaction incubation steps.
Owing to the observed slow dissociation of the LytU–metal ion complexes in the NMR spectra, we resorted to isothermal titration calorimetry (ITC) to glean the information on zinc ion binding affinity and thermodynamics (Supplementary Fig. S7 and Table S2). The ITC data indicated that binding affinity for the first site is very high: Kd values are 0.26 and 0.22 nM for the Ile and Lys forms of LytU, respectively. These values are yet higher than the Kd = 18.5 nM determined for the LytM domain of N. meningitidis protein NMB031526. Binding of the second zinc, although weaker by three orders of magnitude, is still submicromolar (0.32 and 0.49 µM for LytU Ile and Lys forms, respectively) and thus physiologically relevant.
We sought to identify additional side chains that would coordinate the second zinc ion in LytU. Of the available spatially proximal polar residues, N148 side chain showed large chemical shift perturbations (CSPs) in the 1H, 15N HSQC spectrum upon uptake of the second zinc ion. The residue Q152 side chain could also reach the histidine-coordinated ion. However, the N148A or N148S/Q152A mutations did not abolish binding of the second zinc, effectively eliminating them as candidates. Curiously, pentaglycine cleavage experiments revealed that N148A lost its activity. Its 1H, 15N HSQC showed a perfectly well-folded protein (Supplementary Fig. S4) with CSPs located in the neighbourhood of the asparagine when compared to the wild-type LytU, thus excluding the lack of proper folding as the cause of loss of activity.
Binding of the second zinc is pH-dependent
We followed the behaviour of histidine δ2, ε1 peaks in a series of 1H, 13C HSQC spectra acquired from a two-zinc LytU sample as a function of pH. At low pH conditions the 1H, 13C HSQC spectrum is identical to that acquired from a one-zinc LytU sample at same pH (Fig. 6). With the rising pH, signals corresponding to those of the two-zinc form start to appear, and by pH 5.2 peaks of both forms have an approximately equal intensity, until at pH over 6.5 peaks corresponding to the one-zinc form disappear from the two-zinc sample. This indicates that at pH 6.5 and above, if zinc ions are present, the catalytic histidines exist in an inhibited two-zinc form. The 1H, 13C HSQC spectra of apo and one-zinc LytU drastically differ for the whole studied pH range (4.0–8.2), indicating that binding of the first zinc ion to LytU is pH-independent.
LytU structures
LytU shares the overall fold found in other lysostaphin peptidases, in which the prominent common feature is the groove formed by five β-strands flanked by four loops (Fig. 7 and Supplementary Table S2). The one- and two-zinc LytU structures can be superimposed with an RMSD over backbone atoms in β-strands of 0.4 Å (Fig. 7e). However, in the two-zinc LytU form the average local displacement of backbone atoms is significantly smaller in loop β6-β7, adjacent to the catalytic histidines, as well as in the side chain heavy atoms of H125 and H157. This is likely to be the outcome of structural rigidity entailed by zinc ion coordination to H125 and H157 as well as ensuing outer sphere effects. The latter include the appearance of S146 and T149 hydroxyl NOEs in the two-zinc LytU, resulting from stabilization of these protons through e.g. hydrogen bonding. Interestingly, 15N relaxation data (Supplementary Fig. S8) show that the region encompassing residues 64–75 in the N-terminal loop becomes more rigid upon binding the second zinc ion. This might originate from residue Y67 taking part in secondary zinc ion binding interactions. A catalytic role has been suggested for the corresponding tyrosine in LytM13.
LytU is strikingly similar to LytM (Fig. 7f). The immediate surroundings of the catalytic histidines are, however, dissimilar, which lays bases for the different affinities for the second zinc. Due to the likely conformational restrictions induced by P290 as well as the presence of several polar residues in the β6-β7 loop in LytM, the catalytic histidines in LytM reside in a more constricted and polar environment than those in LytU. Most importantly, in LytM serine S287 resides next to the catalytic histidines whereas in LytU the unique, hydrophobic residue I151 is packed between them. These distinct interactions with the aromatic rings are likely to influence histidine pKas and their ability to coordinate zinc ions.
Discussion
In comparison with other lysostaphin-related endopeptidases, LytU is relatively short, consisting only of an N-terminal membrane anchor, a linker region, and an endopeptidase domain. We showed that the enzyme is bound to the plasma membrane and that the endopeptidase domain resides outwards the membrane. Deletion and overexpression experiments both indicated that LytU has a direct role in the opening of the CW PG network for separation of daughter cells during cell division. The situation is quite intriguing as we have no evidence on specific cleavage and release of the LytU endopeptidase domain into the CW, and Matias and Beveridge have shown by cryo-EM that a periplasmic space exists in S. aureus, the thickness of which is about 16 nm in the cell envelope as well as in the septum27. Consequently, if the linker region is in a fully extended form the membrane-bound endopeptidase domain of LytU can reach about ~2/3 of the distance between the membrane and PG. But is the release of the endopeptidase domain needed in vivo? Considering, that the cell is a continuously moving, flexible structure it is most likely that occasionally the periplasmic space expands and shrinks, enabling LytU to take part in PG remodelling. Moreover, the tearing edge structure of the LytU mutant seems to be limited to the outermost surface layer of the CW only, which would be consistent with LytU cutting the PG network from the inside at the cell division site. Furthermore, most likely it is neither necessary nor desirable to cut PG completely as the LytU-cleaved PG lattice should be able to reform and stretch with the expansion, and eventually to smooth out into the newly synthesised CW. Regulated limited cleavage of PG pentaglycine bridges from the inside would ensure that the CW is never completely opened.
Though LytU is not strictly needed in cell division, as shown by the deletion data and normal CW dimensions in EM pictures, its involvement cannot be excluded. This calls for attention to the regulation of LytU activity. Particularly so, as we demonstrated that purified LytU is an effective anti-bacterial agent that lyses S. aureus cells, the very same cells it originates from. Although other related autolytic enzymes, e.g. LytM and NMB0315, possess large auto-inhibitory domains20, 26, the 26–48 residue region upstream of the catalytic domain in LytU has no effect on catalysis in vitro and therefore it does not serve in any apparent regulatory function. Naturally, it is possible that this region serves in other functions, like protein–protein or protein–CW component interactions, or simply acts as an entropic spring that may direct the role of the protein. Our in vitro NMR spectroscopic structural and functional characterization of soluble LytU revealed two mechanisms that can explain how the enzyme is regulated: LytU catalytic activity is sensitive to pH and metal ion content. A simple molecular model (Fig. 8, Supplementary Fig. 10) illustrates how acidity and metal ion availability controls the catalytic activity of LytU. At low pH, protons incapacitate catalytic H125 and 157, whereas, at higher pH, an excess of Zn2+ acts the same.
The pH-sensitivity of CW autolysins is a well-known phenomenon28. Its cellular mechanism was recently elucidated for S. aureus AtlA, whose pH-dependent control of autolysis activity was demonstrated to be the outcome of an intimate interaction between membrane proton gradient and wall teichoic acids, WTAs29. WTAs, which are bound to PG of CW, and lipoteichoic acids (LTAs), which are tethered to the cell membrane but extend through the periplasmic space into PG as well, are zwitterionic CW polymers. Together they are referred to as teichoic acids (TAs). Due to their extensive phosphate group network, TAs contribute to the bulk of negative charge in the CW, which is counterbalanced by protons. Together they orchestrate the pH in CW and activity of AltA. The ability of itinerant metal ions to compete for the negative charges of TAs adds a new dimension to the observed LytU regulation.
Blood concentrations of zinc are in 9.2–20 µM range and the ion is trafficked by anionic phosphate in CW. To date, the most comprehensive and consolidating model of metal ion binding was proposed by Thomas and Rice in isolated B. subtilis CW30. It was described as an electrostatic phenomenon at low ionic strengths and two zones of binding were demonstrated: strong initial binding followed by a negative cooperativity-induced weaker binding. These can depend on the environment of the cell. The overall Kd values for Ca2+ and Mg2+ at pH 5.65 were 1.43 and 1.49 µM, respectively. Taking into account similar values determined for Zn2+, Ca2+, and Mg2+ in unrelated studies, as well as our data for the first and second zinc binding sites (Kd values 0.2–0.3 nM and 0.32–0.49 µM, respectively), it can be concluded that both LytU sites can successfully compete with CW for metal ion binding.
We observed that overproduction of LytU-Strep completely blocks daughter cell separation and that LytU is found exclusively in the plasma membrane where it has an even distribution. This calls for specific localisation or activation of LytU at the site of septal assembly. It is quite likely that assembly of all the components involved in the formation of the septa for cell division, and subsequent synthesis of the new plasma membrane excludes, for example, electron transfer and ATP-synthesis complexes from the area from which the CW will be cleaved. This alone could lead to changes in local pH (proton gradient) and subsequently in concentrations of divalent cations (either transported or already present in the CW). It could also locally alter the distance between the membrane-bound LytU and PG substrate during the CW opening. This would be in accordance with overproduced C-terminally Strep-tagged LytU completely and specifically distorting the assembly and abolishing cutting of CW PG at the cell division sites.
The inhibitory effect of a second zinc in a dinuclear zinc site has been described for several zinc proteases, such as carboxypeptidase A31, thermolysin32 and subclass B2 metallo-β-lactamases33, but to our knowledge, LytU is to date the only member of the M23 glycylglycine endopeptidase family shown to bind two zinc ions, and thereby potentially influence its activity.
Alluring similarities were found between LytU and CphA, a B2 β-lactamase from Aeromonas hydrophila. Despite their different overall structures and substrates (CphA has an αββα fold typical for metallo-β-lactamases, in which a ββ sandwich is surrounded by helices34), the two proteins share some key features. First, their zinc-coordinating atoms structurally align nicely (Supplementary Fig. S9) although the proteins differ by one zinc-coordinating residue: H159 of LytU corresponds to C221 in CphA. In CphA a water molecule participates in the coordination of the second inhibitory zinc. Second, the Kd1 and Kd2 values of zinc ion binding are in a similar range, <20 nM and 46 μM, and 0.2 nM and 0.3 μM for CphA and LytU, respectively. And third, in both proteins binding of the second Zn is pH-dependent, with increasing inhibition at higher pH33. Considering our fruitless mutational experiments of polar side chains to find additional zinc-coordinating residues in LytU and the structural and functional similarities between LytU and CphA we presume that water can act as a ligand for the zinc ion also in LytU. This water molecule is not likely to be stable in LytU because the nearby protons showed no pertinent NOE signals. The fourth ligand in CphA is a sulfate ion from the crystallization solution. Our NMR sample contained solely ZnCl2. In principle, also chloride could occupy the vacant coordination position(s). This type of coordination has been observed in Carboxypeptidase A31. In this enzyme, a distorted tetrahedral coordination, formed by one glutamate carboxylate oxygen, two water molecules and a chloride ion, is observed for the second zinc ion.
The binding of zinc ion to the catalytic histidines H118 and H196 in CphA prevents them from exercising their roles in the catalysis. Specifically, H118 acts as a general base to activate a water molecule and H196 polarizes the carbonyl oxygen of the β-lactam bond by forming a hydrogen bond34. The very recent structure of LytM in complex with a substrate analogue13 revealed details on the M23 lysostaphin peptidase family catalytic mechanism. Analogously to CphA, LytM H260 and H291 are essential for catalysis. The first histidine abstracts a proton from a water molecule generating a nucleophilic hydroxide ion, which subsequently attacks the carbonyl carbon of the peptide bond. The second histidine stabilizes the tetrahedral transition state. The inhibitory zinc ion in LytU acts in a manner similar to that proposed for CphA. LytU 1H, 15N HMBC data clearly indicates that the corresponding histidines H125 and H157 coordinate the zinc ion in the 2Zn form which renders them incapable of performing their roles in catalysis.
The participation of Y204 in the catalytic mechanism of LytM has been exposed13. Its hydroxyl group can stabilize the tetrahedral transition state. This residue corresponds to LytU Y67, which is structurally oriented like Y204 in LytM, pointing towards the catalytic zinc ion, thereby suggesting a similar role in pentaglycine cleavage for Y67 as well. This is further supported by LytU(70–192) being catalytically inactive yet preserving its structural integrity.
LytU catalytic domain exhibits canonical features of lysostaphin/LytM kin and secondary structures of LytU and its closest homologue LytM are faithfully superimposable with very similar orientations of active site residues. Nonetheless, the role of loop β6-β7 in catalytic activity has not been previously reported. Interestingly, mutation N148A abolished enzyme activity completely although it did not have any influence on the structural integrity of LytU nor binding of second zinc. Most surprisingly, the residue 151, which is unique among the family, is obligatory for the enzyme to be active. Our attempts to produce a LytM protein with the equivalent Ile and Lys insertions were unsuccessful, as it appeared that the mutations made LytM insoluble.
Materials and Methods
Generation of LytU deletion mutant
The sa0205::intron mutation (LytU deficient mutant strain) was constructed into the S. aureus Newman strain using TargeTron system (Sigma-Aldrich) as previously described35. Mutating L1.LtrB intron insertion was made at position 237/238 in the sa0205 gene using primers IBS, EBSS1d, and EBS2 with the specific sequences listed in Supplementary Table S1. The resulting new strain RH7796 was verified by sequencing.
Generation of LytU overexpression construct
For controlled expression and detection of LytU expression in cells a plasmid shuttle vector was modified as previously described35. Complete sa0205 gene with an added C-terminal Strep-tag II tail was cloned between the EcoRI and BamHI sites in pEPSA5 vector (primers SA0205 pEP fw and SA0205 pEP rv, Supplementary Table S1). The resulting plasmid pKTH3813 was verified by sequencing and then transferred from E. coli DH5α first to S. aureus RN4220 and then into the Newman strain to yield strains RH7777 and RH7781, respectively.
Construction of GFP-LytU fusion protein
pWKD56f E. coli-S. aureus shuttle plasmid36 was modified for expression of GFPuv4-LytU in S. aureus and determination of LytU localization pattern in the cell as follows. The NotI-PstI fragment of pWKD56f containing the Pxyl-gfpuv4 construct was PCR-amplified with the Pxylgfp4 primers (Supplementary Table S1) and inserted into pWKD56f cut with NotI and PstI. This replacement was performed to insert AvrII and PacI restriction sites after the coding sequence of GFPuv4. The obtained plasmid pJUNK1 was then cut with AvrII and PacI to insert the PCR amplified coding sequence of LytU to which the same restriction sites were added with primers SA0205pMK4 (Supplementary Table S1) in frame with gfpuv4. The obtained plasmid pJUNK2 was then cut with PacI and PstI to add a synthetic transcription terminator t1R between the restriction sites (t1R primers, Supplementary Table S1) to yield plasmid pJUNK3. This plasmid was transformed into S. aureus RN4220 with selection for chloramphenicol resistance (10 µg/ml). pJUNK3 is a derivative of pMK4 (the accession number of pMK4 in GenBank is EU549779) with the replicon of pC194 having the copy number of 15 per cell.
Production of purified recombinant proteins
For purification of different forms of recombinant proteins, chromosomal DNA from S. aureus Newman strain was used as the original PCR template. Primers used in this study have been listed in Supplementary Table S1 and the expression vector used was pGEX-2T to which inserts were cloned between the BamH1 and EcoR1 cloning sites. Constructs were confirmed by sequencing. Point mutants were obtained using QuikChange II site-directed mutagenesis kit (Agilent Technologies, USA) with the pGEX-2T carrying the previously cloned wild-type fragment as a template and results were confirmed by sequencing. For protein expression, all plasmids were transformed into E. coli BL21 (DE3) cells. Purification was carried out utilizing GST-tag and followed by subsequent tag cleavage with thrombin and removal in size exclusion chromatography. Detailed procedures for expression and purification of the proteins for structural and catalytic activity studies are provided in Supplementary Information.
Fractionation
For localising LytU in cellular fractions overexpression strain RH7781 with and without 1% xylose induction was used. Cells grown in BHI medium were harvested with low-speed centrifugation, resuspended in 20 mM Tris pH 7.5 buffer, and ruptured using French Press. Lysate was cleared of cell debris by low-speed centrifugation (13 000 g, 4 °C) in 2 ml Eppendorf tubes and a second centrifugation of the supernatant was carried out in Beckman ultracentrifuge, 4 °C, 20 000 rpm, sw 41 rotor for 2 h to create the membrane containing pellet which was then dissolved in buffer. Samples of all fractions were analyzed in SDS-polyacryl amide mini gels and gels were stained with Coomassie blue using standard methods. When whole cells of S.aureus strains were analyzed in protein gels a brief treatment with lysostaphin (Sigma-Aldrich, USA) was used prior to sample preparation.
Immunolocalization
S. aureus RH7781 was grown in BHI medium and 0.02% xylose was added at the cell density of Klett 70 to induce LytU-Strep expression for 1 hour after which cultures were harvested. Cells from 1 ml of culture were suspended in 0.1 ml of the protoplast buffer (20 mM potassium phosphate pH 7.5, 15 mM MgCl2 and 20% sucrose) containing 0.1 mg/ml lysostaphin for 40 min at 37 °C. Adequate success of protoplast conversion (clear majority) was verified with microscopic examination and cells were then harvested by centrifugation at 5 000 rpm in an Eppendorf miniSpin Plus centrifuge for 5 min. The protoplast pellet was resuspended in 0.1 ml of protoplast buffer containing 1 mg/ml trypsin and then incubated for 40 min at 37 °C. A parallel sample was incubated in a similar manner but without trypsin. After the trypsin treatment trypsin inhibitor was added to the final concentration of 1.2 mg/ml. The protoplasts and protoplast supernatant were heated in Laemmli sample buffer for 10 min at 100 °C and samples were then analysed for LytU-Strep, PrsA and TrxA levels with immunoblotting using anti-Strep-tag, anti-PrsA and anti-TrxA antibodies, respectively.
Microscopy
Light and electron microscopy were carried out as previously described35. For light microscopy samples were Gram-stained. Confocal microscopy for LytU spatial localization in the membrane was carried out as follows. S. aureus RN4220 carrying pJUNK3 was cultivated in BHI medium in the presence of chloramphenicol (10 µg/ml) and 0.5% xylose was added at the cell density of OD600 0.6 to induce GFPuv4-LytU. Samples were prepared for microscopy after 2 h induction. Cells from 1 ml of culture were harvested by centrifugation, washed once with 1 ml of PBS and resuspended in the same volume of PBS. A small drop of the cell suspension (2 µl) was spotted on a microscope slide, coved with a cover slip, and sealed with nail polish. The microscopy of the sample and non-induced control was performed with a Leica TCS-SP5 confocal laser-scanning microscope with excitation at 488 nm.
Cell lysis experiments
The activity of purified LytU fragments against whole S. aureus cells was carried out using a Bioscreen C apparatus (Growth Curves, Finland) and autolysis experiment procedure as previously described35. Substrate cells were in this study grown either to logarithmic growth phase (3 h) or late stationary phase (fresh overnight cultures) prior to harvesting and substrate sample preparation. Samples were prepared in 20 mM Tris-HCl pH 7.0 buffer. Final concentrations of cations or EDTA were 0.05 mM and the final concentration of exogenous LytU, except for controls, was 4 μM.
Enzyme activity measurement
Pentaglycine cleavage by recombinant proteins was carried out in multiple independent series of incubation samples and normalized to the activity of LytU-Ile with one Zn2+ ion. For protein comparison, incubations included 0.03–0.04 mM purified protein and 1–2 mM pentaglycine (Sigma-Aldrich) in PBS buffer. ZnCl2, CuCl2 and CoCl2 solutions were added as respective sources of metal ions to the desired protein-ion ratio. All incubations had 90% v/v D2O as a solvent for water signal suppression, and their total volume was 300 μl. Before the NMR analysis, reactions were incubated, in their linear range, for up to 70 hours and quenched by heating the samples for 15 min at 85 °C.
All incubations were carried out at 37 °C except when different temperatures were tested. Sodium phosphate buffers (150 mM) were used to test the effect of different pH. Before NMR analysis 0.5 mM trimethylsilyl propanoic acid (TSP) was added as a standard. Reaction progress and product formation were observed by recording a 1H spectrum at 37 °C with a Varian INOVA 800 MHz spectrometer manually or with a Bruker AVANCE 600 MHz spectrometer equipped with an autosampler. Data were processed with Bruker TopSpin 3.5 and integrated with Amix 3.9.12.
Assignment of pentaglycine and its cleavage products was performed with a 1H, 13C HMBC experiment in PBS buffer having 99% v/v D2O as a solvent. These data were acquired at 37 °C on a Bruker AVANCE III HD 800 MHz spectrometer, equipped with a TCI 1H/13C/15N cryoprobe. The stability of the substrate pentaglycine over the time span of the activity assay was studied with a control experiment presented in Supplementary Fig. S3.
Isothermal titration calorimetry
ITC experiments were carried out at 35 °C using a MicroCal VP-ITC microcalorimeter. Purified catalytic domains of LytU were dialyzed extensively against cacodylate (Note: Extremely hazardous substance!) buffer (50 mM cacodylic acid, 100 mM NaCl, pH 7.4) to remove phosphate ions of the original purification buffer and subsequently concentrated. Titrations were carried out with 50 μM protein in the calorimeter cell and syringe contained 800 μM ZnCl2 dissolved in the final cacodylate dialysis buffer. Typical injection volume was 7 μl, a spacing between injections was 300 s, and stirring speed was 300 rpm. Baseline was obtained by titrating zinc chloride into the dialysate without protein and was subtracted from the sample titration experiments. The protein-zinc binding isotherms were generated by the nonlinear least-square fitting method of the data and employing a two-site model with MicroCal Origin 7 software. Thermodynamic parameters were obtained as mean values of at least two independent measurements.
Protein NMR spectroscopy
NMR samples had a protein concentration of 0.5 mM in 20 mM Bis-Tris pH 6.5 buffer, and contained 7% D2O, except for histidine-optimized 1H, 15N HMBC spectra, where water was fully substituted with D2O. The tautomeric state of histidines and the Zn-coordination mode were derived from the cross peak patterns37 observed in histidine-optimized 1H, 15N HMBC spectra acquired from the 0, 1Zn and 2Zn forms of LytU. For zinc-coordinating histidines, this analysis was in accord with the coordination mode determined from the Cδ1, Cε1 chemical shift difference38.
LytU(49–192) chemical shift assignment has been described previously39. NOESY spectra for structure determination were acquired at 35 °C on a Varian INOVA 800 MHz spectrometer equipped with a cryogenic probe head. Distance restraints were derived from 3D 1H, 15N NOESY-HSQC, 1H, 13C NOESY-HSQC and histidine nitrogen frequency-optimized 2D 1H, 15N NOESY-HSQC spectra. Structures were determined by the automated procedure in Cyana 2.140 with the KEEP option for four manually assigned NOE peaks in both the 1Zn and 2Zn calculations. These assignments restrain distances between the first and the second β strands. We included one zinc in both structure calculations, with four restraints: the distance of H76 Nε2, D80 Oδ1 and H159 Nδ1 to Zn was restrained to 2.0–2.2 Å, and H76/H159 Cγ to Zn to 4.1–4.3 and 3.0–3.2 Å, respectively. Water is likely to complete the coordination sphere, but we found no evidence for a stable water molecule in the NOE spectra. Hence, no restraints for a fourth ligand were used. Out of 300 structures generated with Cyana, fifteen with the lowest target function were selected for subsequent AMBER 1441 minimization in explicit solvent. The atomic coordinates and structural restraints for 1Zn and 2Zn protein structures have been deposited in the Protein Data Bank (PDB) with the accession codes 5KQB and 5KQC.
Data Availability
The accession codes for atomic coordinates and structural restraints of 1Zn and 2Zn protein structures in the Protein Data Bank (PDB) are 5KQB and 5KQC, respectively.
Electronic supplementary material
Acknowledgements
The study was supported by the grants from Academy of Finland (number 288235) and Sigrid Juselius foundation to P.P. and the Helsinki Graduate Program in Biotechnology and Molecular Biology to V.R. We acknowledge CSC-IT Center for Science Ltd. for the allocation of computational resources. We are grateful to Dr Raili Seppala-Lehto for useful discussions. We thank Dr Maarit Hellman for assistance with ITC and Dr Hannu Maaheimo for the help with pentaglycine cleavage measurements by NMR. We thank Prof. Jan Maarten van Dijl for giving the TrxA antibody.
Author Contributions
P.P. conceived and coordinated the study. J.J., V.K. and K.H. designed, performed and analysed the LytU cellular localization experiments. J.J. performed cell lysis experiments, overexpression experiments and EM studies. V.R. produced proteins and carried out pentaglycine cleavage and ITC experiments. H.T., V.R., O.A. and P.P. designed, performed, and analysed the NMR experiments. All authors wrote the article and reviewed the results and approved the final version of the manuscript.
Competing Interests
The authors declare that they have no competing interests.
Footnotes
Vytas Raulinaitis and Helena Tossavainen contributed equally to this work.
Electronic supplementary material
Supplementary information accompanies this paper at doi:10.1038/s41598-017-06135-w
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Boucher HW. Challenges in anti-infective development in the era of bad bugs, no drugs: a regulatory perspective using the example of bloodstream infection as an indication. Clin Infect Dis. 2010;50(Suppl 1):S4–9. doi: 10.1086/647937. [DOI] [PubMed] [Google Scholar]
- 2.Hanaki H, et al. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J Antimicrob Chemother. 1998;42:199–209. doi: 10.1093/jac/42.2.199. [DOI] [PubMed] [Google Scholar]
- 3.Livermore DM. Antibiotic resistance in staphylococci. Int J Antimicrob Agents. 2000;16(Suppl 1):S3–10. doi: 10.1016/S0924-8579(00)00299-5. [DOI] [PubMed] [Google Scholar]
- 4.Pietiainen M, et al. Transcriptome analysis of the responses of Staphylococcus aureus to antimicrobial peptides and characterization of the roles of vraDE and vraSR in antimicrobial resistance. BMC Genomics. 2009;10:429. doi: 10.1186/1471-2164-10-429. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kuroda M, et al. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol Microbiol. 2003;49:807–821. doi: 10.1046/j.1365-2958.2003.03599.x. [DOI] [PubMed] [Google Scholar]
- 6.Patron RL, Climo MW, Goldstein BP, Archer GL. Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin. Antimicrob. Agents Chemother. 1999;43:1754–1755. doi: 10.1128/aac.43.7.1754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Kokai-Kun JF, Walsh SM, Chanturiya T, Mond JJ. Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model. Antimicrob. Agents Chemother. 2003;47:1589–1597. doi: 10.1128/AAC.47.5.1589-1597.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Kokai-Kun JF, Chanturiya T, Mond JJ. Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model. J Antimicrob Chemother. 2007;60:1051–1059. doi: 10.1093/jac/dkm347. [DOI] [PubMed] [Google Scholar]
- 9.Kokai-Kun JF, Chanturiya T, Mond JJ. Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice. J Antimicrob Chemother. 2009;64:94–100. doi: 10.1093/jac/dkp145. [DOI] [PubMed] [Google Scholar]
- 10.Placencia, F. X., Kong, L. & Weisman, L. E. Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin. Pediatr. Res. 65, 420-424, doi:10.1203/PDR.0b013e3181994a53 (2009). [DOI] [PubMed]
- 11.Jagielska E, Chojnacka O, Sabala I. LytM Fusion with SH3b-Like Domain Expands Its Activity to Physiological Conditions. Microb Drug Resist. 2016;22:461–469. doi: 10.1089/mdr.2016.0053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Osipovitch DC, Griswold KE. Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent. FEMS Microbiol. Lett. 2015;362:1–7. doi: 10.1093/femsle/fnu035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Grabowska M, Jagielska E, Czapinska H, Bochtler M, Sabala I. High resolution structure of an M23 peptidase with a substrate analogue. Sci. Rep. 2015;5:14833. doi: 10.1038/srep14833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Firczuk, M., Mucha, A. & Bochtler, M. Crystal structures of active LytM. J. Mol. Biol. 354, 578-590, doi:S0022-2836(05)01161-7 [pii] (2005). [DOI] [PubMed]
- 15.Iversen OJ, Grov A. Studies on lysostaphin. Separation and characterization of three enzymes. Eur. J. Biochem. 1973;38:293–300. doi: 10.1111/j.1432-1033.1973.tb03061.x. [DOI] [PubMed] [Google Scholar]
- 16.Bastos MD, Coutinho BG, Coelho ML. Lysostaphin: A Staphylococcal Bacteriolysin with Potential Clinical Applications. Pharmaceuticals (Basel) 2010;3:1139–1161. doi: 10.3390/ph3041139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Sugai M, et al. Purification and molecular characterization of glycylglycine endopeptidase produced by Staphylococcus capitis EPK1. J. Bacteriol. 1997;179:1193–1202. doi: 10.1128/jb.179.4.1193-1202.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Simmonds RS, Pearson L, Kennedy RC, Tagg JR. Mode of action of a lysostaphin-like bacteriolytic agent produced by Streptococcus zooepidemicus 4881. Appl. Environ. Microbiol. 1996;62:4536–4541. doi: 10.1128/aem.62.12.4536-4541.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Zhou, R., Chen, S. & Recsei, P. A dye release assay for determination of lysostaphin activity. Anal. Biochem. 171, 141–144, doi:0003-2697(88)90134-0 [pii] (1988). [DOI] [PubMed]
- 20.Odintsov, S. G., Sabala, I., Marcyjaniak, M. & Bochtler, M. Latent LytM at 1.3A resolution. J. Mol. Biol. 335, 775-785, doi:S0022283603013901 [pii] (2004). [DOI] [PubMed]
- 21.Thumm G, Gotz F. Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus. Mol. Microbiol. 1997;23:1251–1265. doi: 10.1046/j.1365-2958.1997.2911657.x. [DOI] [PubMed] [Google Scholar]
- 22.Spencer, J., Murphy, L. M., Conners, R., Sessions, R. B. & Gamblin, S. J. Crystal structure of the LasA virulence factor from Pseudomonas aeruginosa: substrate specificity and mechanism of M23 metallopeptidases. J. Mol. Biol. 396, 908–923, doi:10.1016/j.jmb.2009.12.021 (2010). [DOI] [PubMed]
- 23.Fujiwara T, et al. Mutation analysis of the histidine residues in the glycylglycine endopeptidase ALE-1. J. Bacteriol. 2005;187:480–487. doi: 10.1128/JB.187.2.480-487.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Hyyrylainen HL, et al. Penicillin-binding protein folding is dependent on the PrsA peptidyl-prolyl cis-trans isomerase in Bacillus subtilis. Mol Microbiol. 2010;77:108–127. doi: 10.1111/j.1365-2958.2010.07188.x. [DOI] [PubMed] [Google Scholar]
- 25.Krishnappa L, Monteferrante CG, Neef J, Dreisbach A, van Dijl JM. Degradation of extracytoplasmic catalysts for protein folding in Bacillus subtilis. Appl Environ Microbiol. 2014;80:1463–1468. doi: 10.1128/AEM.02799-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Wang X, et al. Crystal structure of outer membrane protein NMB0315 from Neisseria meningitidis. PLoS One. 2011;6:e26845. doi: 10.1371/journal.pone.0026845. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Matias VR, Beveridge TJ. Native cell wall organization shown by cryo-electron microscopy confirms the existence of a periplasmic space in Staphylococcus aureus. J Bacteriol. 2006;188:1011–1021. doi: 10.1128/JB.188.3.1011-1021.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Calamita HG, Doyle RJ. Regulation of autolysins in teichuronic acid-containing Bacillus subtilis cells. Mol. Microbiol. 2002;44:601–606. doi: 10.1046/j.1365-2958.2002.02872.x. [DOI] [PubMed] [Google Scholar]
- 29.Biswas R, et al. Proton-binding capacity of Staphylococcus aureus wall teichoic acid and its role in controlling autolysin activity. PLoS One. 2012;7:e41415. doi: 10.1371/journal.pone.0041415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Thomas KJ, 3rd, Rice CV. Revised model of calcium and magnesium binding to the bacterial cell wall. Biometals. 2014;27:1361–1370. doi: 10.1007/s10534-014-9797-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Gomez-Ortiz M, Gomis-Ruth FX, Huber R, Aviles FX. Inhibition of carboxypeptidase A by excess zinc: analysis of the structural determinants by X-ray crystallography. FEBS Lett. 1997;400:336–340. doi: 10.1016/S0014-5793(96)01412-3. [DOI] [PubMed] [Google Scholar]
- 32.Holland DR, Hausrath AC, Juers D, Matthews BW. Structural analysis of zinc substitutions in the active site of thermolysin. Protein science: a publication of the Protein Society. 1995;4:1955–1965. doi: 10.1002/pro.5560041001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Hernandez Valladares M, et al. Zn(II) dependence of the Aeromonas hydrophila AE036 metallo-beta-lactamase activity and stability. Biochemistry. 1997;36:11534–11541. doi: 10.1021/bi971056h. [DOI] [PubMed] [Google Scholar]
- 34.Bebrone C, et al. The structure of the dizinc subclass B2 metallo-beta-lactamase CphA reveals that the second inhibitory zinc ion binds in the histidine site. Antimicrob. Agents Chemother. 2009;53:4464–4471. doi: 10.1128/AAC.00288-09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Jonsson IM, et al. Inactivation of the Ecs ABC transporter of Staphylococcus aureus attenuates virulence by altering composition and function of bacterial wall. PLoS One. 2010;5:e14209. doi: 10.1371/journal.pone.0014209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Tu Quoc PH, et al. Isolation and characterization of biofilm formation-defective mutants of Staphylococcus aureus. Infect Immun. 2007;75:1079–1088. doi: 10.1128/IAI.01143-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Pelton, J. G., Torchia, D. A., Meadow, N. D. & Roseman, S. Tautomeric states of the active-site histidines of phosphorylated and unphosphorylated IIIGlc, a signal-transducing protein from Escherichia coli, using two-dimensional heteronuclear NMR techniques. Protein Sci. 2, 543–558, doi:10.1002/pro.5560020406 (1993). [DOI] [PMC free article] [PubMed]
- 38.Barraud P, Schubert M, Allain FH. A strong 13C chemical shift signature provides the coordination mode of histidines in zinc-binding proteins. J. Biomol. NMR. 2012;53:93–101. doi: 10.1007/s10858-012-9625-6. [DOI] [PubMed] [Google Scholar]
- 39.Raulinaitis V, Tossavainen H, Aitio O, Seppala R, Permi P. 1H, 13C and 15N resonance assignments of the new lysostaphin family endopeptidase catalytic domain from Staphylococcus aureus. Biomol NMR Assign. 2016 doi: 10.1007/s12104-016-9722-7. [DOI] [PubMed] [Google Scholar]
- 40.López-Méndez B, Güntert P. Automated Protein Structure Determination from NMR Spectra. J. Am. Chem. Soc. 2006;128:13112–13122. doi: 10.1021/ja061136l. [DOI] [PubMed] [Google Scholar]
- 41.Case DA, et al. The Amber biomolecular simulation programs. J. Comput. Chem. 2005;26:1668–1688. doi: 10.1002/jcc.20290. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Baba T, Schneewind O. Target cell specificity of a bacteriocin molecule: a C-terminal signal directs lysostaphin to the cell wall of Staphylococcus aureus. EMBO J. 1996;15:4789–4797. [PMC free article] [PubMed] [Google Scholar]
- 43.Lu JZ, Fujiwara T, Komatsuzawa H, Sugai M, Sakon J. Cell wall-targeting domain of glycylglycine endopeptidase distinguishes among peptidoglycan cross-bridges. J. Biol. Chem. 2006;281:549–558. doi: 10.1074/jbc.M509691200. [DOI] [PubMed] [Google Scholar]
- 44.Nielsen H, Engelbrecht J, Brunak S, von Heijne G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 1997;10:1–6. doi: 10.1093/protein/10.1.1. [DOI] [PubMed] [Google Scholar]
- 45.Tusnady GE, Simon I. The HMMTOP transmembrane topology prediction server. Bioinformatics. 2001;17:849–850. doi: 10.1093/bioinformatics/17.9.849. [DOI] [PubMed] [Google Scholar]
- 46.Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 1993;234:779–815. doi: 10.1006/jmbi.1993.1626. [DOI] [PubMed] [Google Scholar]
- 47.Larkin MA, et al. Clustal W and Clustal X version 2.0. Bioinformatics. 2007;23:2947–2948. doi: 10.1093/bioinformatics/btm404. [DOI] [PubMed] [Google Scholar]
- 48.Pettersen EF, et al. UCSF Chimera–a visualization system for exploratory research and analysis. J. Comput. Chem. 2004;25:1605–1612. doi: 10.1002/jcc.20084. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The accession codes for atomic coordinates and structural restraints of 1Zn and 2Zn protein structures in the Protein Data Bank (PDB) are 5KQB and 5KQC, respectively.